Registration - In-house Corporation

CannaPharm / Marie-Ève Danis, présidente

Registration Information

In-house Corporation name: CannaPharm
Responsible Officer Name: Marie-Ève Danis, présidente
Initial registration start date: 2019-01-11
Registration status: Inactive
Registration Number: 941888-363670

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 2 of 3 (2019-01-12 to 2020-01-07)

Registration versions:

Version 2 of 3 (2019-01-12 to 2020-01-07)

Lobbying Information

Subject Matters

Agriculture

Subject Matter Details

Policies or Program

Communiquer avec des titulaires de charges publiques sur les politiques et les programmes du gouvernement à l'égard du cannabis.

Communication Techniques

Written communication
Oral communication

Government Institutions

Canada Foundation for Innovation
Export Development Canada (EDC)
Health Canada (HC)

In-house Corporation Details

Description of activities

Centre d'Excellence en cannabis médical, agriculture et science. Les activités de l'entreprise sont la culture, l'analyse, l'extraction, la transformation, la recherche et le développement pour le cannabis à des fins médicales.

Responsible officer name and position during the period of this registration

Marie-Ève Danis, présidente

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
3000 - 1 Place Ville-Marie
Montréal, QC H3B 4N8
Canada

Telephone number: 450-818-7263

Parent Company Information

CannaPharm is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

CannaPharm does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Marie-Ève Danis, présidente | No public offices held
Claude Surprenant, vice-président | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

/CannaPharm

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
/CannaPharm	2019-01-11	2020-07-16

CannaPharm

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

CannaPharm / Marie-Ève Danis, présidente

Registration Information

Associated Communications

Version 2 of 3 (2019-01-12 to 2020-01-07)

Version 2 of 3 (2019-01-12 to 2020-01-07)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Registration - In-house Corporation

CannaPharm / Marie-Ève Danis, présidente

Version 2 of 3 (2019-01-12 to 2020-01-07)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

/CannaPharm

The following names have been used on or after July 2, 2008

CannaPharm

Marie-Ève Danis, présidente (Corporation)